CervoMed Inc.

CRVO

$2.54

-3.79%

N/A-$0.10

Healthcare

Biotechnology

NASDAQ

Active Trading

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
John J. Alam	Co-Founder, Chief Executive Officer, President & Director	USD 952,940	—	1962	Active
William Robert Elder	Chief Financial Officer, General Counsel & Corporate Secretary	USD 643,664		1983	Active
Kelly Blackburn	Executive Vice President of Clinical Development	USD 609,939		1964	Active
Sylvie L. Gregoire	Co-Founder & Director	USD 40,000	—	1961	Active
Mark A. De Rosch	Executive Vice President of Regulatory, Government Affairs & Program Management	—	—	1964	Active
Marinus Verwijs	Executive Vice President of Technical Operations	—	—	1976	Active
Claudia Ordonez	Senior Vice President of Medical Science	—	—	1966	Active
Matthew Winton	Chief Commercial & Business Officer	—	—	1978	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer